AMENDMENT TO THE PALATIN TECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANTSPalatin Technologies Inc • February 14th, 2024 • Pharmaceutical preparations • New York
This Amendment (this “Amendment”), dated as of January 24, 2024 (the “Effective Date”), is made and entered into by and between the Palatin Technologies, Inc., a Delaware corporation (the “Company”), and __________________ (the “Designee”) and relates to (i) the common stock purchase warrant to purchase up to ____ shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an exercise price of $6.875 per share, issued by the Company issued by the Company to the Designee on November 2, 2022 (the “November 2022 Warrants”) and (ii) the Common Stock purchase warrant to purchase up to 1,179 shares of the Company’s Common Stock, at an exercise price of $2.65 per share, issued by the Company to the Designee on October 24, 2023 (the “October 2023 Warrants,” and collectively, with the November 2022 Warrants, the “Warrants”).
ASSET PURCHASE AGREEMENT between COSETTE PHARMACEUTICALS, INC. and PALATIN TECHNOLOGIES, INC. Dated as of December 19, 2023Asset Purchase Agreement • February 14th, 2024 • Palatin Technologies Inc • Pharmaceutical preparations • New Jersey
ASSET PURCHASE AGREEMENT (this “Agreement”) dated as of December 19, 2023 by and between COSETTE PHARMACEUTICALS, INC., a Delaware corporation headquartered at 200 Crossing Blvd, Bridgewater, NJ 08807 (“Purchaser”), and PALATIN TECHNOLOGIES, INC., a Delaware corporation headquartered at 4B Cedar Brook Drive, Cranbury, New Jersey, 08512 (“Seller”).
